Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy

Acta Obstetricia et Gynecologica Scandinavica

Volumn 78, Issue 5, 1999, Pages 452-457

  Kamura, Toshiharu ^a   Shigematsu, Toshiyuki ^a   Kaku, Tsunehisa ^a   Shimamoto, Tomihiro ^a   Saito, Toshiaki ^a   Sakai, Kunihiro ^a   Mitsumoto, Masamune ^a   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Pelvic lymph node metastasis; Radical hysterectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; UTERINE CERVIX CARCINOMA;

EID: 0032928859     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.1999.780520.x     Document Type: Article

References (15)

1. 1. Mitani Y, Fujii J, Miyamura M, Ishizu S, Matsukado M. Lymph node metastases of carcinoma of the uterine cervix. Am J Obstet Gynecol 1962; 84: 515-22.
2. 2. Hsu CT, Cheng YS, Su SC. Prognosis of uterine cervical cancer with extensive lymph node metastases. Am J Obstet Gynecol 1972; 114: 954-62.
3. 3. Burghardt E, Pickel H. Local spread and lymph node involvement in cervical cancer. Obstet Gynecol 1978; 52: 138-45.
4. 4. Fuller AF, Elliot N, Kosloff C, Lewis Jr JL. Lymph node metastases from carcinoma of the cervix, stage IB and IIA: Implication for prognosis and treatment. Gynecol Oncol 1982; 13: 165-74.
5. 5. Noguchi H, Shiozawa I, Sakai Y, Yamazaki T, Fukuta T. Pelvic lymph node metastasis of uterine cervical cancer. Gynecol Oncol 1987; 27: 150-8.
6. 6. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990; 65: 1923-7.
7. 7. Burghardt E, Pickel H, Haas J, Lahousen M. Prognostic factors and operative treatment of stages IB to IIB cervical cancer. Am J Obstet Gynecol 1987; 156: 988-96.
8. 8. Kamura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyama T, Akazawa K et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 1992; 9: 181-6.
9. 9. van Nagell JR, Donaldson ES, Wood EG, Parker Jr JC. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer 1978; 41: 228-34.
10. 10. Matsuyama T, Inoue I, Tsukamoto N, Kashimura M, Kamura T, Saito T et al. Stage Ib, IIa, and IIb cervix cancer, postsurgical staging, and prognosis. Cancer 1984; 54: 3072-7.
11. 11. Perez CA, Camel M, Askin F, Breaux S. Endometrial extension of carcinoma of the cervix: a prognostic factor that may modify staging. Cancer 1981; 48: 170-8 0.
12. 12. Dixon WJ, Brown MB, Engelman L, Hill MA, Jennrich RI. BMDP Statistical Software Manual. Berkeley: University of California Press, 1988.
13. 13. Creasman WT. Editorial. New gynecologic staging. Gynecol Oncol 1995; 58: 157-8.
14. 14. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic lymph node metastases in cervical carcinoma. Obstet Gynecol 1975; 46: 507-10.
15. 15. Boyce JG, Fruchter RG, Nicastri AD, Deregt RH, Ambiavagar P, Reinis M et al. Vascular invasion in stage I carcinoma of the cervix. Cancer 1984; 53: 1175-80.